There are many people who have been following the profit margins of VNUS Medical Technologies very closely. In the past year, stocks have risen considerably for this vein treatment product maker.
Successful lawsuits and plans for growth are believed to have significantly increased the value of VNUS Medical Technologies in the past quarter. The information will be made official when VNUS releases its second quarter results.
The company has announced that those results will be released after the close of the market on July 29th. That means that things could change in the stock world for people who have invested in this vein treatment maker.
Learn more here.
Question of the Day: Is VNUS going to continue to be a wise stock investment?
